Page 159 - 2021_03-Haematologica-web

Macrophage ferritinophagy supports erythropoiesis
Haematologica. 2019;104(7):1342-1354.
11. Nai A, Pettinato M, Federico G, Olivari V, Carlomagno F, Silvestri L. Tamoxifen ery- throid toxicity revealed by studying the role of nuclear receptor co-activator 4 in erythropoiesis. Haematologica. 2019;104
(8):e383-e384.
12. Jelkmann W, Bohlius J, Hallek M,
Sytkowski AJ. The erythropoietin receptor in normal and cancer tissues. Crit Rev Oncol Hematol. 2008;67(1):39-61.
13. Nai A, Lidonnici MR, Rausa M, et al. The second transferrin receptor regulates red blood cell production in mice. Blood. 2015;125(7):1170-1179.
14. Yang B, Kirby S, Lewis J, Detloff PJ, Maeda N, Smithies O. A mouse model for beta 0- thalassemia. Proc Natl Acad Sci U S A. 1995;92(25):11608-11612.
15. Fleming RE, Holden CC, Tomatsu S, et al. Mouse strain differences determine severi- ty of iron accumulation in Hfe knockout model of hereditary hemochromatosis. Proc Natl Acad Sci U S A. 2001;98(5):2707- 2711.
16. Levy JE, Montross LK, Cohen DE, Fleming MD, Andrews NC. The C282Y mutation causing hereditary hemochromatosis does not produce a null allele. Blood. 1999;94(1):9-11.
17. Mastrogiannaki M, Matak P, Keith B, Simon MC, Vaulont S, Peyssonnaux C. HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice. J Clin Invest.
2009;119(5):1159-1166.
18. Shah YM, Matsubara T, Ito S, Yim SH,
Gonzalez FJ. Intestinal hypoxia-inducible transcription factors are essential for iron absorption following iron deficiency. Cell Metab. 2009;9(2):152-164.
19. Fiorito V, Geninatti Crich S, Silengo L, Altruda F, Aime S, Tolosano E. Assessment of iron absorption in mice by ICP-MS measurements of (57)Fe levels. Eur J Nutr. 2012;51(7):783-789.
20. Kaur S, Raggatt LJ, Millard SM, et al. Self- repopulating recipient bone marrow resi- dent macrophages promote long-term hematopoietic stem cell engraftment. Blood. 2018;132(7):735-749.
21. Beattie L, Sawtell A, Mann J, et al. Bone marrow-derived and resident liver macrophages display unique transcriptom- ic signatures but similar biological func- tions. J Hepatol. 2016;65(4):758-768.
22.Artuso I, Pettinato M, Nai A, et al. Transient decrease of serum iron after acute erythropoietin treatment contributes to hepcidin inhibition by ERFE in mice. Haematologica. 2018;104(3):e87-e90.
23. Mirciov CSG, Wilkins SJ, Hung GCC, Helman SL, Anderson GJ, Frazer DM. Circulating iron levels influence the regula- tion of hepcidin following stimulated ery- thropoiesis. Haematologica. 2018;103(10): 1616-1626.
throferrone as an erythroid regulator of iron metabolism. Nat Genet. 2014;46(7): 678-684.
25. Gardenghi S, Ramos P, Marongiu MF, et al. Hepcidin as a therapeutic tool to limit iron overload and improve anemia in beta-tha- lassemic mice. J Clin Invest. 2010;120(12): 4466-4477.
26.Li H, Rybicki AC, Suzuka SM, et al. Transferrin therapy ameliorates disease in beta-thalassemic mice. Nat Med. 2010;16 (2):177-182.
27. Nai A, Pagani A, Mandelli G, et al. Deletion of TMPRSS6 attenuates the phenotype in a mouse model of beta-thalassemia. Blood. 2012;119(21):5021-5029.
28. Schwartz AJ, Das NK, Ramakrishnan SK, et al. Hepatic hepcidin/intestinal HIF-2alpha axis maintains iron absorption during iron deficiency and overload. J Clin Invest. 2019;129(1):336-348.
29. Zhang Z, Zhang F, An P, et al. Ferroportin1 deficiency in mouse macrophages impairs iron homeostasis and inflammatory responses. Blood. 2011;118(7):1912-1922.
30. Nairz M, Theurl I, Swirski FK, Weiss G. "Pumping iron"-how macrophages handle iron at the systemic, microenvironmental, and cellular levels. Pflugers Arch. 2017; 469(3-4):397-418.
31.Bellelli R, Castellone MD, Guida T, et al. NCOA4 transcriptional coactivator inhibits activation of DNA replication origins. Mol Cell. 2014;55(1):123-137.
24.
Kautz L, Jung G, Valore EV, Rivella S, Nemeth E, Ganz T. Identification of ery-
haematologica | 2021; 106(3)
805